Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
13 mg [14C]-A4250 capsule----3件: 93, 297, 338 💬
2[A4250]----3件: 296, 297, 338 💬
3[Maralixibat]1件: Maralixibat2件: Maralixibat ,
Maralixibat chloride 💬 		2件: SLC10A1,
SLC10A2 💬 		3件: Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬2件: 296, 338 💬
4A4250----4件: 93, 296, 297, 338 💬
5A4250 (1200 µg)----1件: 338 💬
6A4250 (200 µg)----1件: 338 💬
7A4250 (400 µg)----1件: 338 💬
8A4250 (600 µg)----1件: 338 💬
9A4250 (odevixibat)1件: Odevixibat2件: Odevixibat ,
Odevixibat hydrate 💬 		1件: SLC10A2 💬 1件: Bile secretion 💬1件: 338 💬
10CRC (A3384)----3件: 93, 297, 338 💬
11Livmarli----2件: 297, 338 💬
12Livmarli Oral Product----2件: 297, 338 💬
13LUM001----4件: 93, 94, 297, 338 💬
14LUM001 (Maralixibat)1件: Maralixibat2件: Maralixibat ,
Maralixibat chloride 💬 		2件: SLC10A1,
SLC10A2 💬 		3件: Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬2件: 297, 338 💬
15Maralixibat1件: Maralixibat2件: Maralixibat ,
Maralixibat chloride 💬 		2件: SLC10A1,
SLC10A2 💬 		3件: Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬4件: 296, 297, 299, 338 💬
16Maralixibat (formely SHP625 or LUM001)1件: Maralixibat2件: Maralixibat ,
Maralixibat chloride 💬 		2件: SLC10A1,
SLC10A2 💬 		3件: Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬3件: 296, 297, 338 💬
17Maralixibat (formely SHP625 or LUM001)Pharmaceutical Form: Oral solutionINN or Proposed INN: MARALIXIBAT CHLORIDECAS Number: 228113-66-4Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 5-Product Name: Maralixibat (formely SHP625 or LUM001)Pharmaceutical Form: Oral solutionINN or Proposed INN: MARALIXIBAT CHLORIDECAS Number: 228113-66-4Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 10-Product Name: Maralixibat (formely SHP625 or LUM001)Pharmaceutical Form: Oral solutionINN or Proposed INN: MARALIXIBAT CHLORIDECAS Number: 228113-66-4Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 15-Product Name: Maralixibat (formely SHP625 or LUM001)Pharmaceutical Form: Oral solutionINN or Proposed INN: MARALIXIBAT CHLORIDECAS Number: 228113-66-4Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 20-1件: Maralixibat2件: Maralixibat ,
Maralixibat chloride 💬 		2件: SLC10A1,
SLC10A2 💬 		3件: Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬3件: 296, 297, 338 💬
18Maralixibat (formerly SHP625 or LUM001)1件: Maralixibat2件: Maralixibat ,
Maralixibat chloride 💬 		2件: SLC10A1,
SLC10A2 💬 		3件: Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬1件: 338 💬
19Maralixibat (in precedenza SHP625 o LUM001)1件: Maralixibat2件: Maralixibat ,
Maralixibat chloride 💬 		2件: SLC10A1,
SLC10A2 💬 		3件: Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬1件: 338 💬
20MARALIXIBAT CHLORIDE1件: Maralixibat2件: Maralixibat ,
Maralixibat chloride 💬 		2件: SLC10A1,
SLC10A2 💬 		3件: Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬3件: 296, 297, 338 💬
21Maralixibat cloruro1件: Maralixibat2件: Maralixibat ,
Maralixibat chloride 💬 		2件: SLC10A1,
SLC10A2 💬 		3件: Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬2件: 296, 338 💬
22MRX Drug Substance (formerly Maralixibat , SHP625 or LUM001)1件: Maralixibat2件: Maralixibat ,
Maralixibat chloride 💬 		2件: SLC10A1,
SLC10A2 💬 		3件: Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬1件: 338 💬
23MRX Drug Substance (formerly Maralixibat, SHP625 or LUM001)1件: Maralixibat2件: Maralixibat ,
Maralixibat chloride 💬 		2件: SLC10A1,
SLC10A2 💬 		3件: Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬1件: 338 💬
24Odevixibat1件: Odevixibat2件: Odevixibat ,
Odevixibat hydrate 💬 		1件: SLC10A2 💬 1件: Bile secretion 💬3件: 296, 297, 338 💬
25Questran----4件: 93, 254, 297, 338 💬
26TAK-625----2件: 297, 338 💬